SRHGF(SRHGF)
SRHGF
FY2027 EPS Estimate
$15.93
FY2027E EPS$15.93
FY2028E EPS$17.89
No analyst ratings available
No analyst price targets available for SRHGF
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7.25%
EPS+9.28%
FY2028
Rev+8.41%
EPS+12.30%
FY2029
Rev+5.56%
EPS+4.08%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $288.46B | $312.71B | $330.11B | $355.30B |
| Low | $279.72B | $303.24B | $320.12B | $344.55B |
| High | $297.73B | $322.77B | $340.73B | $366.73B |
| EBITDA Avg | $28.75B | $31.16B | $32.90B | $35.41B |
| Low | $27.88B | $30.22B | $31.90B | $34.33B |
| High | $29.67B | $32.16B | $33.95B | $36.55B |
| EBIT Avg | $17.03B | $18.47B | $19.49B | $20.98B |
| Low | $16.52B | $17.91B | $18.90B | $20.35B |
| High | $17.58B | $19.06B | $20.12B | $21.66B |
| Net Income Avg | $8.67B | $9.74B | $10.14B | $10.88B |
| Low | $8.33B | $9.36B | $9.74B | $10.45B |
| High | $9.04B | $10.15B | $10.56B | $11.34B |
| EPS Avg | $15.93 | $17.89 | $18.62 | $19.99 |
| Low | $15.30 | $17.18 | $17.88 | $19.20 |
| High | $16.59 | $18.63 | $19.40 | $20.82 |
| Analysts (Rev / EPS) | 9 / 1 | 3 / 1 | 4 / 1 | 4 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions